Literature DB >> 7510474

The X-gene of human hepatitis B virus transactivates the c-jun and alpha-fetoprotein genes.

M X Zhou1, M Watabe, K Watabe.   

Abstract

The X-gene product of human hepatitis B virus is a transacting transcriptional factor which activates a variety of heterologous viral and host promoters/enhancers. We have found that the X-gene product can significantly transactivate the regulatory sequences located at the 5'-upstream of the c-jun oncogene when a reporter plasmid containing the sequences was co-transfected to HepG2 cells with an X-gene expression plasmid. The results of mutational analysis indicate that the X-gene activation requires the AP-1 sequence of the c-jun gene. Furthermore, we also found that the X-gene is capable of activating the 5'-upstream sequence of the alpha-fetoprotein gene. There are at least two elements that respond to the X-gene transactivation. One is located in the sequences between -5,100 and -2,900, and the other is at the C/EBP site. Therefore, the X-gene activates the c-jun and alpha-fetoprotein genes through different host factors, namely AP-1 and C/EBP, respectively. The results of c-jun activation by the X-gene strongly support the previous hypothesis that the X-gene may play a critical role in the development of hepatocellular carcinoma.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7510474     DOI: 10.1007/bf01310574

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  36 in total

1.  trans-activation of viral enhancers by the hepatitis B virus X protein.

Authors:  D F Spandau; C H Lee
Journal:  J Virol       Date:  1988-02       Impact factor: 5.103

2.  A simple and rapid method for the selection of oligodeoxynucleotide-directed mutants.

Authors:  M A Vandeyar; M P Weiner; C J Hutton; C A Batt
Journal:  Gene       Date:  1988-05-15       Impact factor: 3.688

3.  The jun proto-oncogene is positively autoregulated by its product, Jun/AP-1.

Authors:  P Angel; K Hattori; T Smeal; M Karin
Journal:  Cell       Date:  1988-12-02       Impact factor: 41.582

4.  The expression of oncogenes in human developing liver and hepatomas.

Authors:  X K Zhang; D P Huang; D K Chiu; J F Chiu
Journal:  Biochem Biophys Res Commun       Date:  1987-02-13       Impact factor: 3.575

5.  Oncogene expression in the liver tissue of patients with nonneoplastic liver disease.

Authors:  H Haritani; M Esumi; T Uchida; T Shikata
Journal:  Cancer       Date:  1991-05-15       Impact factor: 6.860

6.  Hepatitis B virus DNA integration in a sequence homologous to v-erb-A and steroid receptor genes in a hepatocellular carcinoma.

Authors:  A Dejean; L Bougueleret; K H Grzeschik; P Tiollais
Journal:  Nature       Date:  1986 Jul 3-9       Impact factor: 49.962

7.  Transactivation by the hepatitis B virus X protein depends on AP-2 and other transcription factors.

Authors:  E Seto; P J Mitchell; T S Yen
Journal:  Nature       Date:  1990-03-01       Impact factor: 49.962

8.  trans-activation of viral enhancers including long terminal repeat of the human immunodeficiency virus by the hepatitis B virus X protein.

Authors:  A Siddiqui; R Gaynor; A Srinivasan; J Mapoles; R W Farr
Journal:  Virology       Date:  1989-04       Impact factor: 3.616

9.  Identification of a region within the human immunodeficiency virus type 1 long terminal repeat that is essential for transactivation by the hepatitis B virus gene X.

Authors:  J S Twu; C A Rosen; W A Haseltine; W S Robinson
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

10.  Positive regulation of jun/AP-1 by E1A.

Authors:  R de Groot; N Foulkes; M Mulder; W Kruijer; P Sassone-Corsi
Journal:  Mol Cell Biol       Date:  1991-01       Impact factor: 4.272

View more
  3 in total

1.  Hepatitis Bx antigen stimulates expression of a novel cellular gene, URG4, that promotes hepatocellular growth and survival.

Authors:  N Lale Satiroglu Tufan; Zhaorui Lian; Jie Liu; Jingbo Pan; Patrick Arbuthnot; Michael Kew; Marcy M Clayton; Minghua Zhu; Mark A Feitelson
Journal:  Neoplasia       Date:  2002 Jul-Aug       Impact factor: 5.715

2.  A truncated mutant (residues 58-140) of the hepatitis B virus X protein retains transactivation function.

Authors:  V Kumar; N Jayasuryan; R Kumar
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-28       Impact factor: 11.205

3.  Hepatitis B virus X protein induces expression of alpha-fetoprotein and activates PI3K/mTOR signaling pathway in liver cells.

Authors:  Mingyue Zhu; Junli Guo; Wei Li; Yan Lu; Shigan Fu; Xieju Xie; Hua Xia; Xu Dong; Yi Chen; Ming Quan; Shaojiang Zheng; Keping Xie; Mengsen Li
Journal:  Oncotarget       Date:  2015-05-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.